Abiopharma

New Form EFFECT - Zhongchao Inc. Filed: 2025-06-24 AccNo: 9999999995-25-002003 Size: 1 KB

New Form 6-K - Alvotech Filed: 2025-06-25 AccNo: 0001171843-25-004084 Size: 25 KB

New Form EFFECT - SenesTech, Inc. Filed: 2025-06-24 AccNo: 9999999995-25-002016 Size: 1 KB

New Form 6-K - GALAPAGOS NV Filed: 2025-06-25 AccNo: 0001171843-25-004083 Size: 12 KB

New Form EFFECT - NuCana plc Filed: 2025-06-24 AccNo: 9999999995-25-002004 Size: 1 KB

New Form EFFECT - SenesTech, Inc. Filed: 2025-06-24 AccNo: 9999999995-25-002008 Size: 1 KB

New Form EFFECT - MANGOCEUTICALS, INC. Filed: 2025-06-24 AccNo: 9999999995-25-002015 Size: 1 KB

First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

FDA approve DESIPRAMINE HYDROCHLORIDE

FDA approve TRAZODONE HYDROCHLORIDE

FDA approve DICYCLOMINE HYDROCHLORIDE

FDA approve ALCOHOL

FDA approve BALSALAZIDE DISODIUM

Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQ™ for the Treatment of Childhood Brain Cancer